What kind of funding is available for an early stage health or life science company? How do investors evaluate and valuate health and life science companies? How to finance the growth and internationalization of your company?
Register for our training at Terkko by Monday, Oct 29th to get answers to these and other questions related to startup financing.
During the training, you will get on overview e.g. on the following topics:
- Business Angel’s / Investor’s point of view: criteria for life science startup valuation, what defines investment decisions in practice
- Financing internationalization and growth: what instruments are available for startup companies
- How different financing instruments support growth and at which phase can the instruments be used
Time & location:
Tue, October 30th, 2018, 10–12 a.m. @ Terkko Health Hub
Register via this link by Mon, October 29th
Mikko Leino is an angel investor and a partner at M&M Growth Partners. M&M Growth Partners is a family office and evergreen investor with focus in Growth Companies in Life Sciences, AI and ICT. They are members in the FVCA Finnish Venture Capital Association and FiBAN and work closely with some of the leading players of the field.
Tarja Pitkänen is the founder of Whynot Grow Oy. Tarja has more than 25 years of experience in handling international financial matters, in both the business and banking sectors. Currently, she is focusing on helping early stage companies in financing matters.
Startups, innovators, companies, clinicians, researchers, and students in the fields of life science and health
We hope to see you at Terkko!